Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Time to Perform Lung Function Test in Cystic Fibrosis

This study has been completed.
Information provided by (Responsible Party):
Cecilia Rodriguez, Karolinska University Hospital Identifier:
First received: November 19, 2012
Last updated: November 29, 2012
Last verified: November 2012

Time to perform lung function test after chest physiotherapy in cystic fibrosis.

The investigators study FEV1(forced expiratory volume in one second) and FVC (forced vital capacity).

Condition Intervention
Cystic Fibrosis
Procedure: Lung function test

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Time to Perform Lung Function Test in Cystic Fibrosis After Chest Physiotherapy.

Resource links provided by NLM:

Further study details as provided by Cecilia Rodriguez, Karolinska University Hospital:

Primary Outcome Measures:
  • Lung function test. FEV1 and FVC [ Time Frame: 2 days ]

Enrollment: 24
Study Start Date: February 2008
Study Completion Date: September 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Lung function test
Lung function test
Procedure: Lung function test
Lung function test.
Other Name: Lung function test.

Detailed Description:
The patients perform spirometry before, direct after, 30 minutes, 1 hour, 2 hours, and 3 hours after physiotherapist. The investigators want to study the FEV1 and FVC.

Ages Eligible for Study:   5 Years to 80 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients with cystic fibrosis

Exclusion Criteria:

  • patients with cystic fibrosis who could not stay at the clinic for more than 4 hrs.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01737801

Karolinska University Hospital
Stockholm, Sweden
Sponsors and Collaborators
Karolinska University Hospital
Principal Investigator: Cecilia Rodriguez, Physio Karolinska Institutet
  More Information

Responsible Party: Cecilia Rodriguez, Physiotherapist, Karolinska University Hospital Identifier: NCT01737801     History of Changes
Other Study ID Numbers: 2012-CF-2
Study First Received: November 19, 2012
Last Updated: November 29, 2012

Keywords provided by Cecilia Rodriguez, Karolinska University Hospital:
Lung function

Additional relevant MeSH terms:
Cystic Fibrosis
Pathologic Processes
Pancreatic Diseases
Digestive System Diseases
Lung Diseases
Respiratory Tract Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases processed this record on May 25, 2017